Beckman Coulter, Inc. DxI 9000 Access Immunoassay Analyzer, Catalog #C11137. Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
DxI 9000 Access Immunoassay Analyzer, Catalog #C11137.
Brand
Beckman Coulter, Inc.
Lot Codes / Batch Numbers
Software versions 1.17.0 or below, UDI-DI 15099590732103.
Products Sold
Software versions 1.17.0 or below, UDI-DI 15099590732103.
Beckman Coulter, Inc. is recalling DxI 9000 Access Immunoassay Analyzer, Catalog #C11137. due to When a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS) and is running with the system software versions 1.17. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
When a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS) and is running with the system software versions 1.17.0 and below, the analyzer does not send a message to the LAS when the sample wheel is full, and the LAS continues sending samples despite the limited capacity to process new samples. Therefore, sample tests may be aliquoted but not processed when the number of tests associated with onboard patient samples exceeds the throughput limit. If this issue occurs test results are flagged with a sample wheel timeout (SWT) error flag, and there may be a delay in reporting test results which could lead to a delay in patient treatment.
Recommended Action
Per FDA guidance
The recalling firm issued letters dated 5/16/2024 on 5/22/2024 via postal mail and email notification. The letter described the issue, impact, action, and resolution. Beckman Coulter will implement the correction with a future software release and the consignee will be contacted by their Beckman Coulter service representative to schedule the software upgrade. If the device has been forwarded to another laboratory, the consignee is requested to provide a copy of the letter to that location. A response was requested within 10 days electronically via email or through completion and return of the enclosed Response Form.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026